Senate Bill No. 331, known as the Emerson Kate Cole Act, aims to enhance school medication policies regarding the administration of asthma and anaphylaxis medications. The bill amends existing law to require school employees to call 911 if Epinephrine is administered to a student and mandates that parents or legal guardians be notified if a student experiences a possible allergic reaction. Additionally, the bill stipulates that certain teachers and school employees must undergo annual training on food allergies, recognizing anaphylaxis, and administering Epinephrine, with documentation of this training retained in personnel files.

The bill also updates statutory language and references, including the requirement for parental or legal guardian authorization for students to self-administer medications. It specifies that school districts must inform parents or legal guardians about the administration of medications and the associated liability waivers. Furthermore, it allows school districts to maintain a minimum supply of Epinephrine injectors and inhalers on-site while clarifying that there is no obligation for districts to do so. The act is set to take effect on July 1, 2025, and includes an emergency clause for immediate implementation upon passage.